Versigent PLC Reports Strong Q1 2026 Earnings with Positive Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy VGNT?
Source: seekingalpha
- Significant Revenue Growth: Versigent PLC reported Q1 revenue of $2.2 billion, reflecting a 9% year-over-year increase and a 3% adjusted growth, showcasing the company's strong performance in the global market, particularly in engineering-led solutions.
- Profitability Outlook: The company expects adjusted EBITDA for 2026 to range between $950 million and $1.03 billion, with an EBITDA margin of approximately 10.7%, indicating management's confidence in future profitability despite challenges from commodity price fluctuations.
- Cash Flow Management: Free cash flow is projected to be between $200 million and $300 million for the year, including about $70 million in separation-related costs, demonstrating the company's financial robustness and cash generation capability post-spin-off.
- Shareholder Return Plan: Versigent plans to declare an initial dividend of $0.13 per share following the end of Q2 and has authorized a $250 million share repurchase, reflecting the company's commitment to creating shareholder value and boosting market confidence.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VGNT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VGNT
Wall Street analysts forecast VGNT stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 39.000
Low
Averages
High
Current: 39.000
Low
Averages
High
About VGNT
Versigent PLC is a Switzerland‑based company. The Company is primarily engaged in the automotive components and electrical systems industry. The Company focuses on the design, development, manufacturing, and delivery of signal, data, and power distribution systems for vehicle applications. Their core offerings include electrical architectures as well as physical electrical distribution products.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Significant Revenue Growth: Versigent PLC reported Q1 revenue of $2.2 billion, reflecting a 9% year-over-year increase and a 3% adjusted growth, showcasing the company's strong performance in the global market, particularly in engineering-led solutions.
- Profitability Outlook: The company expects adjusted EBITDA for 2026 to range between $950 million and $1.03 billion, with an EBITDA margin of approximately 10.7%, indicating management's confidence in future profitability despite challenges from commodity price fluctuations.
- Cash Flow Management: Free cash flow is projected to be between $200 million and $300 million for the year, including about $70 million in separation-related costs, demonstrating the company's financial robustness and cash generation capability post-spin-off.
- Shareholder Return Plan: Versigent plans to declare an initial dividend of $0.13 per share following the end of Q2 and has authorized a $250 million share repurchase, reflecting the company's commitment to creating shareholder value and boosting market confidence.
See More
- Q1 Performance: Versigent PLC reported Q1 revenue of $2.12 billion with a net income of $78 million, and an adjusted EBITDA of $203 million, reflecting a stable performance in revenue growth and profitability with a 9.2% EBITDA margin.
- Cash Flow Status: While cash from operations was $36 million, the free cash flow was negative at $(30) million due to $26 million in separation costs, indicating some financial pressure during the initial phase post-spin-off.
- 2026 Financial Guidance: Versigent anticipates revenue between $9.1 billion and $9.4 billion for 2026, with adjusted EBITDA projected at $950 million to $1.03 billion and cash flow from operations expected to be $440 million to $540 million, showcasing confidence in future growth.
- Market Reaction and Valuation: Following UBS's analysis highlighting Versigent's attractive valuation and dividend potential, the stock rallied, indicating increased market confidence in the management's ability to meet financial guidance.
See More
- Significant Revenue Growth: Versigent PLC reported Q1 revenue of $2.212 billion, a 9% increase year-over-year, driven by strong customer demand in North America and Asia Pacific, achieving a 3% adjusted growth despite a decline in global automotive production, indicating robust market performance.
- Net Income and EBITDA Performance: The net income for Q1 was $78 million, down from $95 million in the prior year, yet adjusted EBITDA reached $203 million with a margin of 9.2%, reflecting disciplined operational management and effective execution strategies.
- Capital Allocation and Shareholder Returns: In April 2026, Versigent's board approved a quarterly dividend policy of $0.13 per share and initiated a share repurchase program of up to $250 million, aimed at enhancing market confidence and increasing shareholder value through strategic capital returns.
- 2026 Financial Outlook: The company reaffirmed its full-year 2026 revenue guidance of $9.1 to $9.4 billion, with adjusted EBITDA expected between $950 million and $1.03 billion, demonstrating confidence in future growth despite external economic challenges.
See More
- Earnings Release Schedule: Versigent PLC will release its Q1 2026 financial results on May 5, 2026, after market close, providing financial information based on Aptiv PLC's historical accounting records to ensure transparency and compliance.
- Conference Call Details: CEO Joe Liotine and CFO Doug Ostermann will host a conference call at 4:15 p.m. Eastern Time on the same day, with investors able to participate by dialing +1-800-330-6710 (U.S.) or +1-213-279-1505 (International).
- Investor Conference Participation: Versigent management will participate in several investor conferences in May 2026, including the Evercore Global Auto Ecosystem Conference on May 13 in New York City and the Deutsche Bank Global Autos, Mobility & Robotics Conference on May 19, enhancing engagement with investors.
- Global Business Overview: Versigent provides design and manufacturing of low and high voltage electrical architectures across various industries, including automotive, commercial vehicles, agriculture, and energy storage, with 138,000 employees showcasing strong global scale and regional responsiveness.
See More
- Cybersecurity Investment Opportunity: Berenberg initiates coverage on Palo Alto Networks with a buy rating, highlighting its status as a 'best-in-class' player in cybersecurity, combining multiple growth engines and strong product breadth, which is expected to attract more investor interest in its sustained growth potential.
- Optimistic Tesla Outlook: Bank of America reiterates Tesla as a buy, anticipating that the upcoming Q1 earnings report will focus on its robotaxi deployments aimed at disrupting the rideshare market and capturing a portion of the $1 trillion market opportunity, showcasing its strategic advantage amid increasing competition.
- Packaging Industry Growth Potential: Raymond James upgrades Ball Corp to outperform, citing the company's strong performance in cost pass-throughs and structural support for the beverage sector, predicting it will achieve outsized growth compared to its packaging peers.
- Biopharma Market Prospects: Canaccord initiates AbbVie with a buy rating and a price target of $262, emphasizing its position as a 'core holding' and showcasing its strong growth potential and market appeal in the biopharmaceutical sector.
See More
- Coverage Initiation: UBS has initiated coverage on Versigent PLC (VGNT) with a Buy rating, as analyst Joseph Spak notes that the current implied trading EV/EBITDA multiple is too low compared to other auto industry suppliers, indicating potential value in the stock.
- Capital Return Commitment: Spak highlights that as long as management commits to a consistent capital return program, the stock is likely to re-rate, with approximately 50% of the current market cap expected to be returned to shareholders through buybacks or dividends over the next three years, which could serve as positive catalysts.
- Price Target Setting: UBS has assigned a price target of $43 for Versigent based on a 4.5X multiple to the 2027 EV/EBITDA estimate, reflecting an optimistic outlook on the company's future growth.
- Stock Performance: Versigent's shares rose 5.9% in Tuesday afternoon trading to $32.33, within the post-spinoff trading range of $26.34 to $34.99, indicating a positive market response to the new coverage and outlook.
See More










